Clinical Trials in Philadelphia

Showing 6701-6720 of 15,860 trials

Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients

NCT00697073

This study is meant to assess the safety and tolerability of idebenone in patients with Friedreich's Ataxia over a 12 months period.

Friedreich's Ataxia

Santhera Pharmaceuticals68 participantsStarted Jul 2008

Los Angeles, California, United States • Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

FDG-PET/CT Imaging as Early Predictor of DP

NCT02476734

In this study the investigators would like to describe FDG-PET/CT responses in patients who are receiving CART-19 immunotherapy for Follicular Lymphoma (FL), Diffuse Large B-cell Lymphoma (DLBCL), and Mantle Cell Lymphoma (MCL) as part of UPCC #13413. Subjects will undergo two FDG-PET/CTs. One performed within 6 weeks of CART-19 infusion and a repeat scan at about 1 month after infusion.

Lymphoma

Abramson Cancer Center at Penn Medicine9 participantsStarted Aug 2014

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

NCT02580058

A Phase 3 global study comparing avelumab alone to avelumab plus PLD and to PLD alone to demonstrate that avelumab given alone or in combination with PLD is superior to PLD alone in prolonging Overall Survival in patients with platinum resistant/platinum refractory ovarian cancer.

Ovarian Cancer

Pfizer566 participantsStarted Dec 2015

Chandler, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +292 more locations

Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients

FDG-PET/CT Imaging as Early Predictor of DP

A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)

Find Trials by Condition in Philadelphia

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

TrueTear in Sjogren's Disease Patients

Postpartum Weight Loss for Women at Elevated Cardiovascular Risk

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia

Levocarnitine in Treating Fatigue in Cancer Patients

Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Bucillamine in Treatment of Patients With COVID-19

Noninvasive Biomarkers of Metabolic Liver Disease 1.1

Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies